XV LVAS procedure is to be included in a key medical treatment reimbursement program in the United States. - in regards to this reimbursement when will we be able to see the amounts on the upcoming reports? Will it be this 28th of Feb? It said that the acquisition of Imbio will get to positive cash flow or revenue? Overall, we’ll be seeing positive inflow in the company this half yearly report? It’s just that 4DX has been quiet.
Research, page-2310
-
- There are more pages in this discussion • 651 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.5¢ |
Change
0.045(7.14%) |
Mkt cap ! $277.1M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 70.0¢ | 64.0¢ | $3.052M | 4.525M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 48000 | 67.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.5¢ | 7758 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |